edaxeterkib   Click here for help

GtoPdb Ligand ID: 11411

Synonyms: Example 104 [WO2015051341A1]
Compound class: Synthetic organic
Comment: This entry shows the chemical structure that was submitted to the WHO for the INN edaxeterkib, which is described as a tyrosine kinase inhibitor and antineoplastic. This same chemical structure is claimed in Kura Oncology's patent WO2015051341A1 as an ERK inhibitor (with prior art in WO2015051341A1, Araxes Pharma).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 99.27
Molecular weight 469.22
XLogP 3.19
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES COc1ncc(cn1)c1n[nH]c2c1cc1CN([C@@H]3CCCN(C3)Cc3ccccc3)C(=O)Nc1c2
Isomeric SMILES COc1ncc(cn1)c1n[nH]c2c1cc1CN([C@@H]3CCCN(C3)Cc3ccccc3)C(=O)Nc1c2
InChI InChI=1S/C26H27N7O2/c1-35-25-27-12-19(13-28-25)24-21-10-18-15-33(26(34)29-22(18)11-23(21)30-31-24)20-8-5-9-32(16-20)14-17-6-3-2-4-7-17/h2-4,6-7,10-13,20H,5,8-9,14-16H2,1H3,(H,29,34)(H,30,31)/t20-/m1/s1
1. Li L, Wu T, Feng J, Ren P, Liu Y. (2015)
Inhibitors of erk and methods of use.
Patent number: WO2015051341A1. Assignee: Araxes Pharma Llc. Priority date: 03/10/2013. Publication date: 09/04/2015.